ArticleVirchows Archiv : an international journal of pathology2026
Large B-cell lymphoma associated with fluid overload: two new case reports with molecular insights.
Article in Virchows Archiv : an international journal of pathology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Fluid overload-associated large B-cell lymphoma: two case report and review of literature.Frontiers in oncology · 2025Pooled it
- B-cell lymphoma initially presenting as isolated pleural effusion: a challenging diagnostic case report.Translational cancer research · 2026Article
- Fluid Overload-Associated Large B-Cell Lymphoma Presenting as Isolated Pleural Effusion.Hematology reports · 2026Article
- A Rare Case of Fluid Overload-Associated Large B-Cell Lymphoma in a Patient With Hepatitis C Cirrhosis.ACG case reports journal · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The 5th edition of the World Health Organization (WHO) and the International Consensus Classification (ICC 2022) recently recognized a subtype of diffuse large B cell lymphoma (DLBCL), respectively called fluid overload-associated large B-cell lymphoma (FO-LBCL) and human herpes virus 8 (HHV8)/Epstein-Barr (EBV)-negative primary effusion-based lymphoma. However, few reports have provided a molecular profile for this entity. We present two cases, both females, who presented to our hospital with, respectively, massive pleural and pericardial effusion, but with no other significant pathological findings, and for both of whom FO-LBCL was the final diagnosis. Both cases exhibited activated and germinal center phenotypes but had distinct mutational profiles. In this report, we consider the diagnosis, focusing on the main clinicopathological features that differentiate it from primary effusion lymphoma (PEL) and other DLBCL subtypes. We report the results of a next generation sequencing study carried out to provide new evidence about the molecular pathogenic mechanisms of this rare, recently described entity.
Indexed as
Identifiers
40047901What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.